home / stock / gnpx / gnpx news

GNPX News and Press, Genprex Inc. From 04/20/21

Stock Information
Company Name: Genprex Inc.
Stock Symbol: GNPX
Market: NASDAQ
Website: genprex.com
Menu
GNPX GNPX Quote GNPX Short GNPX News GNPX Articles GNPX Message Board
Get GNPX Alerts

News, Short Squeeze, Breakout and More Instantly...
GNPX - BioMedNewsBreaks - Genprex Inc. (NASDAQ: GNPX) Receives License of Year Award for Advances Made with Gene Therapy Program in Diabetes

Genprex (NASDAQ: GNPX) , a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, was named the recipient of the first-ever License of the Year award presented from the University of Pittsburgh Innovation Institute ( ...
GNPX - Genprex to Receive Inaugural "License of the Year" Award from University of Pittsburgh Innovation Institute in Recognition of Advances Made with Gene Therapy Program in Diabetes

Groundbreaking, potentially curative gene therapy shown to transform alpha cells in the pancreas into functional beta-like cells is potentially applicable to both Type 1 and Type 2 diabetes Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: ...

GNPX - BioMedNewsBreaks - Genprex Inc. (NASDAQ: GNPX) Announces Presentation of Positive REQORSA(TM) Preclinical Data to Audience of World's Leading Cancer Researchers

Genprex (NASDAQ: GNPX) , a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, today announced that its collaborators presented positive preclinical data for TUSC2 immunogene therapy (REQORSA(TM)) in combination with chem...

GNPX - Genprex's Reqorsa combo shows encouraging activity in lung cancer, shares up 3%

Genprex (GNPX) presents positive preclinical data for the combination of TUSC2 immunogene therapy (Reqorsa) in combination with chemotherapy and immunotherapies for the treatment of non-small cell lung cancer ((NSCLC)). These data were presented at the AACR Meeting 2021. The first presentatio...
GNPX - Genprex Collaborators Report Positive Preclinical Data for REQORSA(TM) Immunogene Therapy in Non-Small Cell Lung Cancer at the 2021 AACR Annual Meeting

REQORSA Enhances Efficacy of Chemo-Immune Combination Therapy in KRAS-LKB1 Mutant NSCLC in Humanized Mice REQORSA Overcomes Resistance to Targeted Therapy Osimertinib Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX ), a cl...

GNPX - Best Penny Stocks To Buy In April 2021? 4 Biotechs For Your Watch List

Top Biotech Penny Stocks To Watch If you are looking to invest in penny stocks, there has never been a better time than now. By definition, the term “ penny stock ” refers to stocks that trade under $5. Thanks to this, the low cost provides an interesting entry opportu...

GNPX - Auris Medical, Prometheus Biosciences leads healthcare gainers; Endo International, Odonate Therapeutics among major losers

Gainers: Auris Medical (EARS) +18%, Prometheus Biosciences (RXDX) +15%, Crinetics Pharmaceuticals (CRNX) +13%, Genprex (GNPX) +12%, Fortress Biotech (FBIO) +12%.Losers: Endo International (ENDP) -10%, Odonate Therapeutics (ODT) -9%, Otonomy (OTIC) ...
GNPX - Genprex to Present at the 2021 Virtual Cell & Gene Meeting on the Mediterranean

Company overview to highlight novel gene therapies for cancer and diabetes Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX ), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with ca...

GNPX - Genprex Announces Preclinical Data for TUSC2 Immunogene Therapy in Non-Small Cell Lung Cancer to Be Featured in Two Presentations at the 2021 American Association for Cancer Research Annual Meeting

Two Featured Presentations will Highlight Potential of TUSC2 Immunogene Therapy to Enhance Chemo-Immune Combination Treatments and Overcome Resistance to Osimertinib Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX ), a clinical-st...

GNPX - Genprex to Present at the Spring 2021 Oncology Investor Conference on March 29

Investor presentation to highlight novel gene therapies for cancer and diabetes Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX ), a clinical-stage gene therapy company focused on developing life-changing therapies for patients wi...
Previous 10 Next 10